Search details
1.
Prevention and treatment of papillomavirus-related cancers through immunization.
Annu Rev Immunol
; 29: 111-38, 2011.
Article
in English
| MEDLINE | ID: mdl-21166538
2.
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.
Blood
; 136(26): 3004-3017, 2020 12 24.
Article
in English
| MEDLINE | ID: mdl-32818230
3.
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.
Immunity
; 38(4): 729-41, 2013 Apr 18.
Article
in English
| MEDLINE | ID: mdl-23562161
4.
A novel axis of innate immunity in cancer.
Nat Immunol
; 11(11): 981-2, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20959800
5.
Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.
Immunol Cell Biol
; 94(6): 554-62, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26786233
6.
IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.
J Immunol
; 193(5): 2248-57, 2014 Sep 01.
Article
in English
| MEDLINE | ID: mdl-25063870
7.
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Immunol Rev
; 239(1): 85-98, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21198666
8.
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.
Blood
; 120(15): 3019-29, 2012 Oct 11.
Article
in English
| MEDLINE | ID: mdl-22932803
9.
Role of γδ T cells in α-galactosylceramide-mediated immunity.
J Immunol
; 188(8): 3928-39, 2012 Apr 15.
Article
in English
| MEDLINE | ID: mdl-22412194
10.
Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.
Immunol Cell Biol
; 91(1): 105-14, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23090488
11.
NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.
J Immunol
; 187(4): 1601-8, 2011 Aug 15.
Article
in English
| MEDLINE | ID: mdl-21742969
12.
Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production.
J Immunol
; 184(3): 1242-50, 2010 Feb 01.
Article
in English
| MEDLINE | ID: mdl-20028654
13.
Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.
J Immunol
; 184(10): 5663-9, 2010 May 15.
Article
in English
| MEDLINE | ID: mdl-20410490
14.
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect.
Oncoimmunology
; 11(1): 2081009, 2022.
Article
in English
| MEDLINE | ID: mdl-35712122
15.
Natural killer cell metabolism.
Mol Immunol
; 115: 3-11, 2019 11.
Article
in English
| MEDLINE | ID: mdl-29179986
16.
Interaction of neurotransmitters and neurochemicals with lymphocytes.
J Neuroimmunol
; 332: 99-111, 2019 07 15.
Article
in English
| MEDLINE | ID: mdl-30999218
17.
NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.
Cancer Immunol Res
; 7(6): 952-962, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31053598
18.
V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab.
Int J Cancer
; 122(11): 2526-34, 2008 Jun 01.
Article
in English
| MEDLINE | ID: mdl-18307255
19.
ß-Adrenergic Signaling Impairs Antitumor CD8+ T-cell Responses to B-cell Lymphoma Immunotherapy.
Cancer Immunol Res
; 6(1): 98-109, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29146881
20.
HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3+ T-Cell Migration to Skin.
J Invest Dermatol
; 138(6): 1348-1359, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29277541